2019 | | Effect of Fibroblast Growth Factor-2 and its Receptor Gene Polymorphisms on the Survival of Patients With Hepatitis B Virus-associated Hepatocellular Carcinoma | 김순선, 노충균, 신성재, 은정우, 이기명, 정재연, 조효정 |
2014 | | Effect of virological response to entecavir on the development of hepatocellular carcinoma in hepatitis B viral cirrhotic patients: comparison between compensated and decompensated cirrhosis. | 김순선, 안선주, 임선교, 정재연, 조성원, 황재철 |
2018 | | Effects of the Administration of Probiotics on Fecal Microbiota Diversity and Composition in Healthy Individuals | 노충균, 이광재, 정재연 |
2013 | | Efficacy and safety of entecavir plus carnitine complex (GODEXⓇ) compared to entecavir monotherapy in patient with ALT elevated chronic hepatitis B: randomized, multicenter open-label trials. The GOAL study | 정재연, 조성원 |
2012 | | Efficacy and tolerability of peginterferon alpha plus ribavirin in the routine daily treatment of chronic hepatitis C patients in Korea: a multi-center, retrospective observational study | 정재연, 조성원 |
2014 | | Embolization of percutaneous transhepatic portal venous access tract with N-butyl cyanoacrylate. | 김봉완, 김순선, 김진우, 왕희정, 원제환, 정재연, 조성원 |
2016 | | Endoscopic naso-gallbladder drainage versus gallbladder stenting before cholecystectomy in patients with acute cholecystitis and a high suspicion of choledocholithiasis: a prospective randomised preliminary study | 김순선, 김욱환, 김지훈, 김진홍, 신성재, 양민재, 유병무, 이광재, 이기명, 임선교, 정재연, 조성원, 황재철 |
2011 | | Endoscopic treatment of a large gastric duplication cyst with hook-knife and snare (with video). | 김영배, 김재근, 김진홍, 신성재, 유병무, 이기명, 임선교, 정재연, 황재철 |
2012 | | Entecavir Therapy for Patients with Hepatitis B Virus-related Decompensated Cirrhosis | 정재연, 조성원 |
2018 | | EpCAM as a Predictive Marker of Tumor Recurrence and Survival in Patients Who Underwent Surgical Resection for Hepatocellular Carcinoma | 김봉완, 김순선, 김영배, 노진, 노충균, 양민재, 왕희정, 윤소영, 이길호, 정재연, 조성원, 조효정, 황재철 |
2016 | | Evaluation of the Effectiveness of NK Vue Gold Kit in Patients with Chronic Hepatitis B | 김순선, 임영애, 정재연, 조성원 |
2021 | | Exosomal miRNA panel marker composition for diagnosing early liver cancer for noninvasive in vitro diagnosis | 김순선, 은정우, 정재연, 조효정 |
2008 | | Factors affecting initial virologic response and emergence of resistant mutants after adefovir treatment in lamivudine-resistant chronic hepatitis B patients | 박진선, 정재연, 조성원 |
2009 | | Factors associated with liver stiffness in chronic liver disease | 김영배, 정재연, 조성원 |
2010 | | Factors that affect the diagnostic accuracy of liver fibrosis measurement by Fibroscan in patients with chronic hepatitis B. | 정재연, 조성원 |
2018 | | FRI-151: Treatment and prognosis of hepatic epithelioid hemangioendothelioma based on SEER data analysis from 1973 to 2007 | 김순선, 노오규, 정재연, 조성원, 조효정 |
2012 | | G-Protein Beta3 Subunit C825T Polymorphism in Patients With Overlap Syndrome of Functional Dyspepsia and Irritable Bowel Syndrome | 이광재, 임선교, 정재연, 조성원 |
2006 | | Genetic polymorphism of interferon-gamma, interferon-gamma receptor, and interferon regulatory factor-1 genes in patients with hepatitis B virus infection. | 김진홍, 여말희, 왕희정, 정재연, 조성원, 함기백 |
2016 | | Genetic polymorphisms in the Wnt/beta-catenin pathway genes as predictors of tumor development and survival in patients with hepatitis B virus-associated hepatocellular carcinoma | 김순선, 노충균, 신성재, 유병무, 이광재, 이기명, 정재연, 조성원, 조효정 |
2018 | | GS-003: Sorafenib with versus without concurrent conventional transarterial chemoembolization (cTACE) in patients with advanced hepatocellular carcinoma (HCC): Results from a multicenter, open-label, randomized, controlled phase III STAH trial | 정재연 |
2002 | | H. pylori Infection and Gastric Carcinogenesis | 김명욱, 김영배, 김진홍, 이기명, 정재연, 조성원, 조용관, 주희재, 최준혁, 한상욱, 함기백 |
2019 | | HDAC6 Suppresses Let-7i-5p to Elicit TSP1/CD47-Mediated Anti-Tumorigenesis and Phagocytosis of Hepatocellular Carcinoma | 왕희정, 은정우, 정재연 |
2015 | | High circulating microRNA-122 expression is a poor prognostic marker in patients with hepatitis B virus-related hepatocellular carcinoma who undergo radiofrequency ablation. | 김봉완, 김순선, 김재근, 노충균, 신성재, 왕희정, 이기명, 이제희, 정재연, 조성원, 조효정 |
2017 | | Higher serum interleukin-17A levels as a potential biomarker for predicting early disease progression in patients with hepatitis B virus-associated advanced hepatocellular carcinoma treated with sorafenib | 김보현, 김순선, 김재근, 신성재, 양민재, 유병무, 이광재, 이기명, 이제희, 임선교, 정재연, 조성원, 조효정, 황재철 |
2013 | | How can we predict the presence of missed synchronous lesions after endoscopic submucosal dissection for early gastric cancers or gastric adenomas? | 김동훈, 김진홍, 신성재, 유병무, 유준환, 이광재, 이기명, 임선교, 정재연, 조성원, 황재철 |
2016 | | Identification of NUCKS1 as a putative oncogene and immunodiagnostic marker of hepatocellular carcinoma | 김봉완, 김순선, 김영배, 왕희정, 정재연, 조성원 |
2018 | | Impact of nucleos(t)ide analog treatment on the development of malignancy in patients with chronic hepatitis B | 김순선, 박래웅, 양민재, 정재연, 조성원, 조효정 |
2019 | | Improvement of Nonalcoholic Fatty Liver Disease Reduces the Risk of Type 2 Diabetes Mellitus | 김순선, 김진홍, 신성재, 양민재, 유병무, 이광재, 이기명, 정재연, 조효정, 황재철 |
2014 | | Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma | 김순선, 신성재, 안선주, 유병무, 이기명, 정재연, 조성원, 조효정 |
2012 | | Interleukin-1ß and interleukin-1 receptor accessory protein gene polymorphisms are associated with persistent hepatitis B virus infection | 김순선, 정재연, 조성원 |
2015 | | Interleukin-8 level as a prognostic marker in patients with hepatitis B virus-associated hepatocellular carcinoma treated with transarterial chemoembolization. | 강대용, 김순선, 김재근, 박주한, 신성재, 원제환, 유병무, 이기명, 이제희, 정재연, 조성원, 조효정 |
2004 | | Intra-arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein thrombosis | 김재근, 김진홍, 왕희정, 원제환, 이기명, 정재연, 조성원, 함기백 |
2014 | | Is It Necessary for NAFLD Patients to be Screened for Hepatocellular Carcinoma? | 정재연 |
2021 | | Kit for diagnosing liver cancer comprising an agent capable of measuring expression level of miR-4661-5p | 김순선, 은정우, 정재연, 조효정 |
2021 | | Kit for diagnosing liver cancer comprising an agent capable of measuring expression level of serum exosomal long non-coding RNA | 김순선, 은정우, 정재연, 조효정 |
- | | Kit for diagnosis of early liver cancer | 김순선, 은정우, 정재연, 조효정 |
2005 | | Lack of association between hepatitis B virus infection and polymorphism of mannose-binding lectin gene in Korean population. | 김진홍, 정재연, 조성원, 함기백 |
2015 | | Liver injury in acute hepatitis A is associated with decreased frequency of regulatory T cells caused by Fas-mediated apoptosis. | 정재연 |
2007 | | Liver Stiffness Measurement for the Diagnosis of Hepatic Fibrosis in Patients with Chronic Viral Hepatitis | 김영배, 정재연, 조성원 |
2018 | | Liver volume-based prediction model stratifies risks for hepatocellular carcinoma in chronic hepatitis B patients on surveillance | 김순선, 정재연 |
2019 | | Long-term Outcomes of Antiviral Therapy in Patients With Advanced Chronic HBV Infection | 정재연 |
2010 | | Loss of SM22 is a characteristic signature of colon carcinogenesis and its restoration suppresses colon tumorigenicity in vivo and in vitro. | 김영배, 여말희, 이광재, 정재연, 조성원 |
2010 | | Low efficacy of entecavir therapy in adefovir-refractory hepatitis B patients with prior lamivudine resistance. | 고경현, 이명희, 정재연, 조성원 |
2017 | | Low levels of circulating microRNA-26a/29a as poor prognostic markers in patients with hepatocellular carcinoma who underwent curative treatment | 강대용, 김보현, 김봉완, 김순선, 김재근, 신성재, 양민재, 왕희정, 이기명, 이제희, 정재연, 조성원, 조효정, 황재철 |
2015 | | Low serum interleukin-6 levels as a predictive marker of recurrence in patients with hepatitis B virus related hepatocellular carcinoma who underwent curative treatment. | 김순선, 김재근, 박주한, 왕희정, 정재연, 조성원, 조효정 |
2008 | | Management of Chronic Hepatitis B in Treatment-Naive Patients | 정재연 |
2021 | | Method for diagnosing liver cancer by measuring expression level of miR-4661-5p | 김순선, 은정우, 정재연, 조효정 |
2021 | | Method for diagnosing liver cancer by measuring expression level of serum exosomal long non-coding RNA | 김순선, 은정우, 정재연, 조효정 |
- | | Method for providing information necessary for diagnosis of early liver cancer | 김순선, 은정우, 정재연, 조효정 |
2021 | | Microbiome as a potential diagnostic and predictive biomarker in severe alcoholic hepatitis | 김순선, 은정우, 정재연, 조효정 |
2021 | | microRNA biomarker derived exosome for diagnosis of early liver cancer and use thereof | 김순선, 은정우, 정재연, 조효정 |
2014 | | MicroRNA-196A-2 polymorphisms and hepatocellular carcinoma in patients with chronic hepatitis B | 정재연, 조성원 |
2005 | | MR findings in eosinophilic infiltration of the liver. | 김영배, 김재근, 선주성, 원제환, 이기명, 정재연 |
2013 | | Multicenter comparison of PEG-IFN α2a or α2b plus ribavirin for treatment-naïve HCV patient in Korean population. | 정재연, 조성원 |
2013 | | Multidrug-resistant hepatitis B virus resulting from sequential monotherapy with lamivudine, adefovir, and entecavir: clonal evolution during lamivudine plus adefovir therapy. | 김순선, 정재연, 조성원 |
2011 | | Non-invasive index for predicting significant liver fibrosis: comparison of diagnostic performances in patients with chronic hepatitis B and C | 김영배, 정재연, 조성원 |
2018 | | Nonalcoholic fatty liver disease as a sentinel marker for the development of diabetes mellitus in non-obese subjects | 김순선, 김진홍, 양민재, 임선교, 정재연, 조성원, 조효정 |
2007 | | Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B. | 정재연, 조성원 |
2013 | | Novel method of stent insertion for malignant lower rectal obstruction with proximal releasing delivery system (with video). | 김재근, 김진홍, 신성재, 유병무, 이기명, 임선교, 정재연, 황재철 |
- | | Peptide Therapeutic Agent of Autoimmune Diseases and Inflammatory Diseases | 김순선, 서창희, 정재연 |